Sensitivity and specificity of the World Health Organization pertussis clinical case definition

International Journal of Infectious Diseases

Volumn 14, Issue 12, 2010, Pages

  Ghanaie, Roxana Mansour ^a   Karimi, Abdollah ^a   Sadeghi, Hossein ^a   Esteghamti, Abdolreza ^a   Falah, Fateme ^a   Armin, Shahnaz ^a   Fahimzad, Alireza ^a   Shamshiri, Ahmadreza ^a   Kahbazi, Manige ^a   Shiva, Faride ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Pertussis; Polymerase chain reaction; Sensitivity; Specificity; World Health Organization

Indexed keywords

ARTICLE; BACTERIUM CULTURE; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CHILD; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; IRAN; MAJOR CLINICAL STUDY; NOSE SMEAR; PERTUSSIS; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; THROAT CULTURE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; BACTERIOLOGICAL TECHNIQUES; BORDETELLA INFECTIONS; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CHILD; COUGH; CULTURE MEDIA; FEMALE; HUMANS; IRAN; MALE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; WHOOPING COUGH; WORLD HEALTH ORGANIZATION;

EID: 78649631149     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2010.07.005     Document Type: Article

References (14)

1. Cherry J.D., Grimprel E., Guiso N., Heininger U., Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005, 24(5 Suppl):S25-34.
2. von König C.H., Halperin S., Riffelmann M., Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002, 2:744-750.
3. Vaccines and Biologicals, World Health Organization. Core information for the development of immunization policy. Geneva: WHO; 2002.
4. Iranian Centers for Diseases Control and Prevention. Report 2008. Presented at the 20th International Congress of Pediatrics, October 9-13, 2008, Tehran, Iran.
5. Mattoo S., Cherry J.D. Molecular pathogenesis, epidemiology and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005, 18:326-382.
6. Vaccine Assessment and Monitoring team of the Department of Vaccines and Biologicals, World Health Organization. Recommended standards for surveillance of selected vaccine preventable disease. Geneva: World Health Organization; 2003.
7. Kösters K., Riffelmann M., Wirsing von König C.H. Evaluation of a real-time PCR assay for detection of Bordetella pertussis and Bordetella parapertussis in clinical samples. J Med Microbiol 2001, 50:436-440.
8. Yih W.K., Lett S.M., des Vignes F.N., Garrison K.M., Sipe P.L., Marchant C.D. The increasing incidence of pertussis in Massachusetts adolescents and adults; 1989-1998. J Infect Dis 2000, 182:1409-1416.
9. Baron S., Njamkepo E., Grimprel E., Begue P., Desenclos J., Drucker J., et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 1998, 17:412-418.
10. Senzilet L.D., Halperin S.A., Spika J.S., Alagaratnam M., Morris A., Smith B. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001, 32:1691-1697. Sentinel Health Unit Surveillance System Pertussis Working Group.
11. Patriarca P.A., Biellik R.J., Sanden G., Burstyn D.G., Mitchell P.D., Silverman P.R., et al. Sensitivity and specificity of clinical case definitions for pertussis. Am J Public Health 1988, 78:833-836.
12. Bamberger E., Lahat N., Gershtein V., Gershtein R., Benilevi D., Shapiro S., et al. Diagnosing pertussis: the role of polymerase chain reaction. Isr Med Assoc J 2005, 7:351-354.
13. Cagney M., McIntyre P.B., Heron L., Giammanco A., MacIntyre C.R. The relationship between pertussis symptomatology, incidence and serology in adolescents. Vaccine 2008, 26:5547-5553.
14. Gilberg S., Njamkepo E., Du Châtelet I.P., Partouche H., Gueirard P., Ghasarossian C., et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 2002, 186:415-418.